Table of Contents Chapter 1 Overview of Asthma Drugs 1.1 Definition of Asthma Drugs in This Report 1.2 Commercial Types of Asthma Drugs 1.2.1 Long-term Control Medications 1.2.2 Quick-relief Medications (Rescue Medications) 1.2.3 Medications for Allergy-induced Asthma 1.3 Downstream Application of Asthma Drugs 1.3.1 Hospital Pharmacy 1.3.2 Retail Pharmacy 1.3.3 Online Pharmacy 1.4 Development History of Asthma Drugs 1.5 Market Status and Trend of Asthma Drugs 2013-2023 1.5.1 Global Asthma Drugs Market Status and Trend 2013-2023 1.5.2 Regional Asthma Drugs Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Asthma Drugs 2013-2017 2.2 Sales Market of Asthma Drugs by Regions 2.2.1 Sales Volume of Asthma Drugs by Regions 2.2.2 Sales Value of Asthma Drugs by Regions 2.3 Production Market of Asthma Drugs by Regions 2.4 Global Market Forecast of Asthma Drugs 2018-2023 2.4.1 Global Market Forecast of Asthma Drugs 2018-2023 2.4.2 Market Forecast of Asthma Drugs by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Asthma Drugs by Types 3.2 Sales Value of Asthma Drugs by Types 3.3 Market Forecast of Asthma Drugs by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Asthma Drugs by Downstream Industry 4.2 Global Market Forecast of Asthma Drugs by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Asthma Drugs Market Status by Countries 5.1.1 North America Asthma Drugs Sales by Countries (2013-2017) 5.1.2 North America Asthma Drugs Revenue by Countries (2013-2017) 5.1.3 United States Asthma Drugs Market Status (2013-2017) 5.1.4 Canada Asthma Drugs Market Status (2013-2017) 5.1.5 Mexico Asthma Drugs Market Status (2013-2017) 5.2 North America Asthma Drugs Market Status by Manufacturers 5.3 North America Asthma Drugs Market Status by Type (2013-2017) 5.3.1 North America Asthma Drugs Sales by Type (2013-2017) 5.3.2 North America Asthma Drugs Revenue by Type (2013-2017) 5.4 North America Asthma Drugs Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Asthma Drugs Market Status by Countries 6.1.1 Europe Asthma Drugs Sales by Countries (2013-2017) 6.1.2 Europe Asthma Drugs Revenue by Countries (2013-2017) 6.1.3 Germany Asthma Drugs Market Status (2013-2017) 6.1.4 UK Asthma Drugs Market Status (2013-2017) 6.1.5 France Asthma Drugs Market Status (2013-2017) 6.1.6 Italy Asthma Drugs Market Status (2013-2017) 6.1.7 Russia Asthma Drugs Market Status (2013-2017) 6.1.8 Spain Asthma Drugs Market Status (2013-2017) 6.1.9 Benelux Asthma Drugs Market Status (2013-2017) 6.2 Europe Asthma Drugs Market Status by Manufacturers 6.3 Europe Asthma Drugs Market Status by Type (2013-2017) 6.3.1 Europe Asthma Drugs Sales by Type (2013-2017) 6.3.2 Europe Asthma Drugs Revenue by Type (2013-2017) 6.4 Europe Asthma Drugs Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Asthma Drugs Market Status by Countries 7.1.1 Asia Pacific Asthma Drugs Sales by Countries (2013-2017) 7.1.2 Asia Pacific Asthma Drugs Revenue by Countries (2013-2017) 7.1.3 China Asthma Drugs Market Status (2013-2017) 7.1.4 Japan Asthma Drugs Market Status (2013-2017) 7.1.5 India Asthma Drugs Market Status (2013-2017) 7.1.6 Southeast Asia Asthma Drugs Market Status (2013-2017) 7.1.7 Australia Asthma Drugs Market Status (2013-2017) 7.2 Asia Pacific Asthma Drugs Market Status by Manufacturers 7.3 Asia Pacific Asthma Drugs Market Status by Type (2013-2017) 7.3.1 Asia Pacific Asthma Drugs Sales by Type (2013-2017) 7.3.2 Asia Pacific Asthma Drugs Revenue by Type (2013-2017) 7.4 Asia Pacific Asthma Drugs Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Asthma Drugs Market Status by Countries 8.1.1 Latin America Asthma Drugs Sales by Countries (2013-2017) 8.1.2 Latin America Asthma Drugs Revenue by Countries (2013-2017) 8.1.3 Brazil Asthma Drugs Market Status (2013-2017) 8.1.4 Argentina Asthma Drugs Market Status (2013-2017) 8.1.5 Colombia Asthma Drugs Market Status (2013-2017) 8.2 Latin America Asthma Drugs Market Status by Manufacturers 8.3 Latin America Asthma Drugs Market Status by Type (2013-2017) 8.3.1 Latin America Asthma Drugs Sales by Type (2013-2017) 8.3.2 Latin America Asthma Drugs Revenue by Type (2013-2017) 8.4 Latin America Asthma Drugs Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Asthma Drugs Market Status by Countries 9.1.1 Middle East and Africa Asthma Drugs Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Asthma Drugs Revenue by Countries (2013-2017) 9.1.3 Middle East Asthma Drugs Market Status (2013-2017) 9.1.4 Africa Asthma Drugs Market Status (2013-2017) 9.2 Middle East and Africa Asthma Drugs Market Status by Manufacturers 9.3 Middle East and Africa Asthma Drugs Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Asthma Drugs Sales by Type (2013-2017) 9.3.2 Middle East and Africa Asthma Drugs Revenue by Type (2013-2017) 9.4 Middle East and Africa Asthma Drugs Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Asthma Drugs 10.1 Global Economy Situation and Trend Overview 10.2 Asthma Drugs Downstream Industry Situation and Trend Overview Chapter 11 Asthma Drugs Market Competition Status by Major Manufacturers 11.1 Production Volume of Asthma Drugs by Major Manufacturers 11.2 Production Value of Asthma Drugs by Major Manufacturers 11.3 Basic Information of Asthma Drugs by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Asthma Drugs Major Manufacturer 11.3.2 Employees and Revenue Level of Asthma Drugs Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Asthma Drugs Major Manufacturers Introduction and Market Data 12.1 GlaxoSmithKline 12.1.1 Company profile 12.1.2 Representative Asthma Drugs Product 12.1.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 12.2 Sanofi 12.2.1 Company profile 12.2.2 Representative Asthma Drugs Product 12.2.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of Sanofi 12.3 Roche & Novartis 12.3.1 Company profile 12.3.2 Representative Asthma Drugs Product 12.3.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of Roche & Novartis 12.4 Teva 12.4.1 Company profile 12.4.2 Representative Asthma Drugs Product 12.4.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of Teva 12.5 Merck 12.5.1 Company profile 12.5.2 Representative Asthma Drugs Product 12.5.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of Merck 12.6 AstraZeneca 12.6.1 Company profile 12.6.2 Representative Asthma Drugs Product 12.6.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca 12.7 Boehringer Ingelheim 12.7.1 Company profile 12.7.2 Representative Asthma Drugs Product 12.7.3 Asthma Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim Chapter 13 Upstream and Downstream Market Analysis of Asthma Drugs 13.1 Industry Chain of Asthma Drugs 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Asthma Drugs 14.1 Cost Structure Analysis of Asthma Drugs 14.2 Raw Materials Cost Analysis of Asthma Drugs 14.3 Labor Cost Analysis of Asthma Drugs 14.4 Manufacturing Expenses Analysis of Asthma Drugs Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Long-term Control Medications Table Advantage and Disadvantage of Quick-relief Medications (Rescue Medications) Table Advantage and Disadvantage of Medications for Allergy-induced Asthma Table Sales Volume of Asthma Drugs by Regions 2013-2017 Table Sales Value of Asthma Drugs by Regions 2013-2017 Table Production Volume of Asthma Drugs by Regions 2013-2017 Table Global Sales Volume of Asthma Drugs by Regions 2018-2023 Table Global Sales Value of Asthma Drugs by Regions 2018-2023 Table Global Production Volume of Asthma Drugs by Regions 2018-2023 Table Sales Volume of Asthma Drugs by Types 2013-2017 Table Sales Value of Asthma Drugs by Types 2013-2017 Table Sales Volume Forecast of Asthma Drugs by Types 2018-2023 Table Sales Value Forecast of Asthma Drugs by Types 2018-2023 Table Sales Volume of Asthma Drugs by Downstream Industry 2013-2017 Table Sales Volume Forecast of Asthma Drugs by Downstream Industry 2018-2023 Table North America Asthma Drugs Sales by Countries (2013-2017) Table North America Asthma Drugs Sales Share by Countries (2013-2017) Table North America Asthma Drugs Revenue by Countries (2013-2017) Table North America Asthma Drugs Revenue Market Share by Countries (2013-2017) Table North America Asthma Drugs Sales by Type (2013-2017) Table North America Asthma Drugs Sales Share by Type (2013-2017) Table North America Asthma Drugs Revenue by Type (2013-2017) Table North America Asthma Drugs Revenue Share by Type (2013-2017) Table North America Asthma Drugs Sales by Downstream Industry (2013-2017) Table North America Asthma Drugs Sales Share by Downstream Industry (2013-2017) Table Europe Asthma Drugs Sales by Countries (2013-2017) Table Europe Asthma Drugs Sales Share by Countries (2013-2017) Table Europe Asthma Drugs Revenue by Countries (2013-2017) Table Europe Asthma Drugs Revenue Market Share by Countries (2013-2017) Table Europe Asthma Drugs Sales by Type (2013-2017) Table Europe Asthma Drugs Sales Share by Type (2013-2017) Table Europe Asthma Drugs Revenue by Type (2013-2017) Table Europe Asthma Drugs Revenue Share by Type (2013-2017) Table Europe Asthma Drugs Sales by Downstream Industry (2013-2017) Table Europe Asthma Drugs Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Asthma Drugs Sales by Countries (2013-2017) Table Asia Pacific Asthma Drugs Sales Share by Countries (2013-2017) Table Asia Pacific Asthma Drugs Revenue by Countries (2013-2017) Table Asia Pacific Asthma Drugs Revenue Market Share by Countries (2013-2017) Table Asia Pacific Asthma Drugs Sales by Type (2013-2017) Table Asia Pacific Asthma Drugs Sales Share by Type (2013-2017) Table Asia Pacific Asthma Drugs Revenue by Type (2013-2017) Table Asia Pacific Asthma Drugs Revenue Share by Type (2013-2017) Table Asia Pacific Asthma Drugs Sales by Downstream Industry (2013-2017) Table Asia Pacific Asthma Drugs Sales Share by Downstream Industry (2013-2017) Table Latin America Asthma Drugs Sales by Countries (2013-2017) Table Latin America Asthma Drugs Sales Share by Countries (2013-2017) Table Latin America Asthma Drugs Revenue by Countries (2013-2017) Table Latin America Asthma Drugs Revenue Market Share by Countries (2013-2017) Table Latin America Asthma Drugs Sales by Type (2013-2017) Table Latin America Asthma Drugs Sales Share by Type (2013-2017) Table Latin America Asthma Drugs Revenue by Type (2013-2017) Table Latin America Asthma Drugs Revenue Share by Type (2013-2017) Table Latin America Asthma Drugs Sales by Downstream Industry (2013-2017) Table Latin America Asthma Drugs Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Asthma Drugs Sales by Regions (2013-2017) Table Middle East and Africa Asthma Drugs Sales Share by Regions (2013-2017) Table Middle East and Africa Asthma Drugs Revenue by Regions (2013-2017) Table Middle East and Africa Asthma Drugs Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Asthma Drugs Sales by Type (2013-2017) Table Middle East and Africa Asthma Drugs Sales Share by Type (2013-2017) Table Middle East and Africa Asthma Drugs Revenue by Type (2013-2017) Table Middle East and Africa Asthma Drugs Revenue Share by Type (2013-2017) Table Middle East and Africa Asthma Drugs Sales by Downstream Industry (2013-2017) Table Middle East and Africa Asthma Drugs Sales Share by Downstream Industry (2013-2017) Table Production Volume of Asthma Drugs by Major Manufacturers 2013-2017 Table Production Value of Asthma Drugs by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Asthma Drugs Major Manufacturer Table Employees and Revenue Level of Asthma Drugs Major Manufacturer Table Representative Asthma Drugs Product One of GlaxoSmithKline Table Representative Asthma Drugs Product Two of GlaxoSmithKline Table Asthma Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline 2013-2017 Table Representative Asthma Drugs Product One of Sanofi Table Representative Asthma Drugs Product Two of Sanofi Table Asthma Drugs Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017 Table Representative Asthma Drugs Product One of Roche & Novartis Table Representative Asthma Drugs Product Two of Roche & Novartis Table Asthma Drugs Sales, Revenue, Price and Gross Margin of Roche & Novartis 2013-2017 Table Representative Asthma Drugs Product One of Teva Table Representative Asthma Drugs Product Two of Teva Table Asthma Drugs Sales, Revenue, Price and Gross Margin of Teva 2013-2017 Table Representative Asthma Drugs Product One of Merck Table Representative Asthma Drugs Product Two of Merck Table Asthma Drugs Sales, Revenue, Price and Gross Margin of Merck 2013-2017 Table Representative Asthma Drugs Product One of AstraZeneca Table Representative Asthma Drugs Product Two of AstraZeneca Table Asthma Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca 2013-2017 Table Representative Asthma Drugs Product One of Boehringer Ingelheim Table Representative Asthma Drugs Product Two of Boehringer Ingelheim Table Asthma Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim 2013-2017